{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=therapy&page=82", "query": { "intervention": "therapy", "page": 82 }, "page_size": 10 }, "pagination": { "page": 82, "page_size": 10, "total_count": 83934, "total_pages": 8394, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=therapy&page=83&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=therapy&page=81&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T00:11:02.381Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02857543", "title": "Plant-Based, American Heart Assoc. or Mediterranean Diets In 9-18 yo With BMI >95%, Cholesterol >169 and Their Parents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity", "Hypercholesterolemia", "Cardiovascular Disease" ], "interventions": [ { "name": "Plant-Based Diet", "type": "OTHER" }, { "name": "American Heart Association Diet", "type": "OTHER" }, { "name": "Mediterranean Diet", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "9 Years to 18 Years" }, "enrollment_count": 180, "start_date": "2016-06", "completion_date": "2021-10-25", "has_results": false, "last_update_posted_date": "2021-11-15", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02857543" }, { "nct_id": "NCT01783535", "title": "Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Retinoblastoma" ], "interventions": [ { "name": "vincristine", "type": "DRUG" }, { "name": "topotecan", "type": "DRUG" }, { "name": "filgrastim", "type": "DRUG" }, { "name": "PEG-filgrastim", "type": "DRUG" }, { "name": "carboplatin", "type": "DRUG" }, { "name": "focal therapy", "type": "OTHER" }, { "name": "etoposide", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "MESNA", "type": "DRUG" }, { "name": "doxorubicin", "type": "DRUG" }, { "name": "enucleation", "type": "PROCEDURE" }, { "name": "external beam radiation or proton beam radiation", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE", "RADIATION" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 174, "start_date": "2013-06-19", "completion_date": "2027-02-21", "has_results": true, "last_update_posted_date": "2026-06-29", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01783535" }, { "nct_id": "NCT00479635", "title": "A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "TPI 287", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cortice Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 26, "start_date": "2007-01", "completion_date": "2008-08", "has_results": false, "last_update_posted_date": "2014-01-22", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 6, "location_summary": "Los Angeles, California • Palm Springs, California • Lexington, Kentucky + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palm Springs", "state": "California" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Livingston", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00479635" }, { "nct_id": "NCT04301076", "title": "Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment (\"EPOCH\") for Adult T-Cell Leukemia-Lymphoma (ATLL)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Adult T-Cell Leukemia/Lymphoma", "Adult T-Cell Leukemia/Lymphoma", "Chronic Adult T-Cell Leukemia/Lymphoma", "HTLV-1 Infection" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin Hydrochloride", "type": "DRUG" }, { "name": "Echocardiography Test", "type": "PROCEDURE" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Vincristine Sulfate", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2021-08-31", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-10-29", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 19, "location_summary": "Atlanta, Georgia • City of Saint Peters, Missouri • Creve Coeur, Missouri + 11 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "City of Saint Peters", "state": "Missouri" }, { "city": "Creve Coeur", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04301076" }, { "nct_id": "NCT02258217", "title": "Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Relapsing Remitting Multiple Sclerosis" ], "interventions": [ { "name": "Acthar", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OhioHealth", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2014-06", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2020-09-01", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02258217" }, { "nct_id": "NCT04725240", "title": "Open-Label Study of Setmelanotide in Hypothalamic Obesity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypothalamic Obesity" ], "interventions": [ { "name": "Setmelanotide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rhythm Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "6 Years to 40 Years" }, "enrollment_count": 18, "start_date": "2021-06-07", "completion_date": "2022-06-28", "has_results": true, "last_update_posted_date": "2025-02-07", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 5, "location_summary": "San Diego, California • Gainesville, Florida • Saint Paul, Minnesota + 2 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Saint Paul", "state": "Minnesota" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04725240" }, { "nct_id": "NCT05926050", "title": "The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Reaction Time" ], "interventions": [ { "name": "Treatment (CopaPrime+ (USANA Health Sciences)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "USANA Health Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 41, "start_date": "2021-09-08", "completion_date": "2022-08-10", "has_results": false, "last_update_posted_date": "2023-07-03", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 1, "location_summary": "Park City, Utah", "locations": [ { "city": "Park City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT05926050" }, { "nct_id": "NCT07005050", "title": "Renal Pelvic Denervation Pilot Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Uncontrolled Hypertension" ], "interventions": [ { "name": "RPD", "type": "DEVICE" }, { "name": "Active hypertension medical therapy", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Verve Medical, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 60, "start_date": "2026-01-30", "completion_date": "2029-03-02", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Surprise, Arizona • Los Angeles, California + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Surprise", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Springfield", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT07005050" }, { "nct_id": "NCT04187950", "title": "NECTAR Study: Nectar (Honey) Effects on Comfort, Thoughts, and Regularity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gastrointestinal Dysfunction", "Physiological Stress", "Cognition - Other" ], "interventions": [ { "name": "Yogurt with B. lactis and added honey", "type": "DIETARY_SUPPLEMENT" }, { "name": "Yogurt with heat-inactivated B. lactis and added cane sugar", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of Illinois at Urbana-Champaign", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "22 Years to 64 Years" }, "enrollment_count": 66, "start_date": "2021-05-19", "completion_date": "2022-11-02", "has_results": false, "last_update_posted_date": "2023-07-21", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 1, "location_summary": "Urbana, Illinois", "locations": [ { "city": "Urbana", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04187950" }, { "nct_id": "NCT05358691", "title": "A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lung Cancer Stage III" ], "interventions": [ { "name": "AN0025", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rutgers, The State University of New Jersey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2024-11-01", "completion_date": "2028-06-01", "has_results": false, "last_update_posted_date": "2025-04-16", "last_synced_at": "2026-10-31T00:11:02.381Z", "location_count": 1, "location_summary": "New Brunswick, New Jersey", "locations": [ { "city": "New Brunswick", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05358691" } ] }